# Beam Therapeutics Inc (BEAM) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 07373V105
Page URL: https://superinvestorclub.com/stock/BEAM
Last updated: 2026-08-29T13:45:50.420Z

## Summary

As of the most recent 13F filing period, Beam Therapeutics Inc (BEAM) is held by 1 tracked superinvestors with an aggregate position value of $5.3M representing 0153600 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Stanley Druckenmiller](https://superinvestorclub.com/manager/19) | Duquesne Family Office | 153600 | $5.3M | 0.10% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2025-09-30: 1 holders, $221,658 aggregate, 09133 shares
- 2026-06-30: 1 holders, $5.3M aggregate, 0153600 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "Beam Therapeutics Inc (BEAM) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/BEAM), aggregating SEC 13F, Form 4, and congressional disclosures."